Alkermes (ALKS) Share-based Compensation (2010 - 2026)
Alkermes (ALKS) reported Share-based Compensation of $31.14 million for Q2 2026, up 24.7% from $24.97 million a year earlier but down 14.3% from the prior quarter.
Alkermes (ALKS) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Alkermes' Share-based Compensation came in at $118.41 million, up 30.0% year-over-year; for FY2025, it came in at $98.72 million, up 2.2% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 1.8% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $96.64 million in FY2024 (-4.2%), $100.91 million in FY2023 (+7.1%), $94.25 million in FY2022 (+7.6%) and $87.62 million in FY2021 (-2.8%).
- Five-year quarterly Share-based Compensation spans a low of $18.34 million in Q1 2022 and a high of $36.33 million in Q1 2026.
- Year over year, Share-based Compensation has now increased in each of the last five quarters, with growth averaging 10.7% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q1 2026 (growth of 59.3%); the low point was Q1 2025 (a decline of 30.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $36.33 million (Q1 2026), $26.28 million (Q4 2025) and $24.67 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn | 31.14 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.14 Mn |
| Mar 31, 2026 | 36.33 Mn |
| Dec 31, 2025 | 26.28 Mn |
| Sep 30, 2025 | 24.67 Mn |
| Jun 30, 2025 | 24.97 Mn |
| Mar 31, 2025 | 22.81 Mn |
| Dec 31, 2024 | 20.75 Mn |
| Sep 30, 2024 | 22.53 Mn |
| Jun 30, 2024 | 20.60 Mn |
| Mar 31, 2024 | 32.76 Mn |
| Dec 31, 2023 | 25.84 Mn |
| Sep 30, 2023 | 23.92 Mn |
| Jun 30, 2023 | 28.50 Mn |
| Mar 31, 2023 | 22.64 Mn |
| Dec 31, 2022 | 26.48 Mn |
| Sep 30, 2022 | 26.05 Mn |
| Jun 30, 2022 | 23.38 Mn |
| Mar 31, 2022 | 18.34 Mn |
| Dec 31, 2021 | 19.02 Mn |
| Sep 30, 2021 | 25.60 Mn |
Alkermes Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALKS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();